Luehring Jens 4
4 · Bellerophon Therapeutics, Inc. · Filed Oct 3, 2017
Insider Transaction Report
Form 4
Luehring Jens
Director10% Owner
Transactions
- Purchase
Common Stock Warrants (right to buy)
2017-09-29+10,000→ 10,000 totalExercise: $1.24From: 2018-03-29Exp: 2022-09-29→ Common Stock (10,000 underlying) - Purchase
Common Stock
2017-09-29+10,000→ 80,658 total
Footnotes (1)
- [F1]The reported securities are included within Units purchased by the reporting person for $1.205 per Unit. Each Unit consists of one share of common stock and one warrant to purchase one share of common stock.